Global Central
Venous Catheter Market, by Product Type (Peripherally Inserted Central
Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and
Non-Tunneled Central Venous Catheter),
by Design (Single Lumen, Double Lumen, and Multi Lumen), by Age Group (Adults,
Pediatric, and Geriatric), by Procedure (Cardiovascular Procedure, Chemotherapy
Procedure, and Dialysis Procedure), by End User (Hospitals, Ambulatory Surgical Centre, and Specialty
Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle
East, Africa) is estimated to be valued at US$ 2,002.2 million in 2020 and is expected to exhibit a
CAGR of 6.2 % during the forecast period (2020-2027), as highlighted in a new
report published by Coherent Market Insights.
Major companies are focused on strategic mergers and
acquisitions in order to strengthen their position in the global central venous
catheter market. For instance, in 2018, B.Braun Melsungen AG acquired
bloodlines business of NxStage Medical, Inc. This acquisition helped the dialysis
business of B. Braun Melsungen.
Moreover, companies are focused on innovation and
advancements in central venous catheters to strengthen their share in the
global central venous catheter market. For instance, On April 2020, Bluegrass
Vascular Technologies, a medical technology company, received a De Novo
classification order from the U.S. Food and Drug Administration (FDA) for its
Surfacer Inside-Out Access Catheter System. The system is developed to obtain
central venous access for catheter insertion into the central venous system for
patients with upper body venous occlusions.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2400
Global Central Venous Catheter Market – Impact of Coronavirus
(COVID-19) Pandemic
According to the Coronavirus Disease (COVID-19) Situation
Report- 199 by the World Health Organization, around 18,614,177 cases of
coronavirus disease (COVID-19) were reported on August 6, 2020 across the
globe.
On May 23, 2020 the Centers for Disease Control and
Prevention released an updated interim additional guidelines to prevent the
infection spread in outpatient hemodialysis facilities. Some important
guidelines are facilities should implement non-punitive, and flexible sick
leave for ill healthcare professional, instructions about maintaining social
distancing of at least 6 feet whenever possible, hand hygiene, respiratory
hygiene, and cough etiquette should be provided to patients and ill healthcare
personnel (HCP) as well. Hemodialysis facilities which are carrying out the
dialysis of more than one patient with suspected or confirmed COVID-19 should
provide proper isolation to these patients and the healthcare personnel (HCP)
taking care of patients.
Browse 64 Market Data Tables and 44 Figures spread through
261 Pages and in-depth TOC on “Global Endocrine Testing Market, by Product Type
(Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and
Non-Tunneled Central Venous Catheter),
by Design (Single Lumen, Double Lumen, and Multi Lumen), by Age Group (Adults,
Pediatric, and Geriatric), by Procedure (Cardiovascular Procedure, Chemotherapy
Procedure, and Dialysis Procedure), by End User (Hospitals, Ambulatory Surgical
Center, and Specialty Clinics), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa).
The market is expected to witness significant growth during
the forecast period, as various companies are focusing on strategic mergers and
acquisitions in the global central venous catheter market.
For instance, in 2018, B.Braun Melsungen AG acquired
bloodlines and dialysis business of NxStage Medical, Inc. This acquisition is
expected to facilitate growth of B.Braun Melsungen’s dialysis business.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/central-venous-catheter-market-2400
Key Takeaways of the Global Central Venous Catheter Market:
The global central venous catheter market is expected to
exhibit a CAGR of 6.2% during the forecast period owing to product approvals
and launches and strategic mergers and acquisitions.
Among product type, the peripherally inserted central
catheters (PICC)-central venous catheter market segment is expected to hold
dominant position in the global central venous catheter market in 2020 owing to
approvals of new and advanced products by regulatory authorities.
Among design, the multi lumen-central venous catheter market
segment is expected to hold dominant position in the global central venous
catheter market growth in 2020 due to availability of products with features
such as antimicrobial and antithrombogenic (Arrow PICC), and increasing
incidence of diseases requiring use of multiple lumen catheters.
Among age groups, the adult segment is expected to hold
dominant position in the global central venous catheter market in 2020 owing to
an increasing number of product launches.
Among procedure, the chemotherapy procedure- central venous
catheter market size segment is expected to hold dominant position in central
venous catheter market growth due to the rising incidence of cancer conditions
and patients on chemotherapy requiring multiple medications at times such as
antibiotics, nutritional fluids, and even blood infusion.
Among end user, the hospitals segment is expected to hold
dominant position in the global central venous catheter market in 2020 owing to
increasing hospitalizations for cardiovascular diseases such as heart failure,
heart attack etc.
Among regions, North America central venous catheter market
is expected to hold dominate position in the global central venous catheter
market owing to an increasing number of product launches and approvals
associated with central venous catheters by regulatory bodies in the region.
Key players operating in the global central venous catheter
market are AngioDynamics Inc., Lepu Medical Technology Co., Ltd, KIMAL PLC, Prodimed
Benelux B.V, Terumo Corporation, Medtronic Plc, Teleflex Incorporated, Becton,
Dickinson and Company, Amecath, ICU Medical, Inc., Edwards Lifesciences
Corporation, Cook Group, Nipro Corporation, Bactiguard, Vygon (UK) Ltd,
Guangdong Baihe Medical Technology Co., Ltd, Wujiang Evergreen EX/IM Co., Ltd,
and ZOLL Medical Corporation.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2400
About Coherent
Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
